MOYER CHARLES 4
4 · KING PHARMACEUTICALS INC · Filed Jun 2, 2009
Insider Transaction Report
Form 4
MOYER CHARLES
Director
Transactions
- Sale
Common Stock
2009-06-01$9.48/sh−6,000$56,880→ 24,512 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2009.